2018 IRLSSG临床共识指南:铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病

2018-01-20 国际不宁腿综合征研究组 Sleep Med. 2018 Jan;41:27-44. d

2018年1月,国际不宁腿综合征研究组(IRLSSG)发布了应用铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病的共识指南。 大脑铁缺乏与不宁腿综合征(RLS)的病理生理相关,目前RLS指南指南建议在外周铁水平较低的情况下应用铁剂治疗。 IRLSSG工作小组回顾了这些研究并针对成人不宁腿综合征以及儿童不宁腿综合征/Willis-Ekbom病的铁剂治疗提出共识指南。

中文标题:

2018 IRLSSG临床共识指南:铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病

英文标题:

Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report.

发布日期:

2018-01-20

简要介绍:

2018年1月,国际不宁腿综合征研究组(IRLSSG)发布了应用铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病的共识指南。

大脑铁缺乏与不宁腿综合征(RLS)的病理生理相关,目前RLS指南指南建议在外周铁水平较低的情况下应用铁剂治疗。 IRLSSG工作小组回顾了这些研究并针对成人不宁腿综合征以及儿童不宁腿综合征/Willis-Ekbom病的铁剂治疗提出共识指南。

 

拓展指南:铁剂相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 IRLSSG临床共识指南:铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病)] GetToolGuiderByIdResponse(projectId=1, id=73c471c0015553ad, title=2018 IRLSSG临床共识指南:铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病, enTitle=Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report., guiderFrom=Sleep Med. 2018 Jan;41:27-44. d, authorId=null, author=, summary=2018年1月,国际不宁腿综合征研究组(IRLSSG)发布了应用铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病的共识指南。 大脑铁缺乏与不宁腿综合征(RLS)的病理生理相关,目前RLS指南指南建议在外周铁水平较低的情况下应用铁剂治疗。 IRLSSG工作小组回顾了这些研究并针对成人不宁腿综合征以及儿童不宁腿综合征/Willis-Ekbom病的铁剂治疗提出共识指南。 , cover=, journalId=null, articlesId=null, associationId=1119, associationName=国际不宁腿综合征研究组, associationIntro=null, copyright=0, guiderPublishedTime=Sat Jan 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年1月,国际不宁腿综合征研究组(IRLSSG)发布了应用铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病的共识指南。 <BR><BR>大脑铁缺乏与不宁腿综合征(RLS)的病理生理相关,目前RLS指南指南建议在外周铁水平较低的情况下应用铁剂治疗。 IRLSSG工作小组回顾了这些研究并针对成人不宁腿综合征以及儿童不宁腿综合征/Willis-Ekbom病的铁剂治疗提出共识指南。</P> <P> </P>拓展指南:<strong>与<font color=red>铁剂</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=bdea31c001a5e264" title="2013 KHA-CARI指南:慢性肾病患者铁剂的应用" target=_blank>2013 KHA-CARI指南:慢性肾病患者铁剂的应用</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E9%93%81%E5%89%82" target=_blank>有关铁剂更多指南</a></ul>, tagList=[TagDto(tagId=70186, tagName=铁剂治疗), TagDto(tagId=4154, tagName=不宁腿综合征), TagDto(tagId=70187, tagName=Willis-Ekbom病)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5706, appHits=178, showAppHits=0, pcHits=3881, showPcHits=2533, likes=119, shares=9, comments=2, approvalStatus=1, publishedTime=Wed Feb 14 20:22:10 CST 2018, publishedTimeString=2018-01-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Feb 14 20:22:10 CST 2018, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 08:03:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 IRLSSG临床共识指南:铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病)])
2018 IRLSSG临床共识指南:铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=288407, encodeId=0b2828840e20, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:44 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288163, encodeId=c4eb2881631b, content=好知识.值得学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Feb 15 13:49:41 CST 2018, time=2018-02-15, status=1, ipAttribution=)]
    2018-02-16 131****1460

    学习了受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=288407, encodeId=0b2828840e20, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:44 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288163, encodeId=c4eb2881631b, content=好知识.值得学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Feb 15 13:49:41 CST 2018, time=2018-02-15, status=1, ipAttribution=)]
    2018-02-15 虈亣靌

    好知识.值得学习!

    0